Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment.


Journal

Lancet (London, England)
ISSN: 1474-547X
Titre abrégé: Lancet
Pays: England
ID NLM: 2985213R

Informations de publication

Date de publication:
28 08 2021
Historique:
received: 01 03 2021
revised: 30 04 2021
accepted: 06 05 2021
entrez: 29 8 2021
pubmed: 30 8 2021
medline: 21 9 2021
Statut: ppublish

Résumé

Stillbirths are a major public health issue and a sensitive marker of the quality of care around pregnancy and birth. The UN Global Strategy for Women's, Children's and Adolescents' Health (2016-30) and the Every Newborn Action Plan (led by UNICEF and WHO) call for an end to preventable stillbirths. A first step to prevent stillbirths is obtaining standardised measurement of stillbirth rates across countries. We estimated stillbirth rates and their trends for 195 countries from 2000 to 2019 and assessed progress over time. For a systematic assessment, we created a dataset of 2833 country-year datapoints from 171 countries relevant to stillbirth rates, including data from registration and health information systems, household-based surveys, and population-based studies. After data quality assessment and exclusions, we used 1531 datapoints to estimate country-specific stillbirth rates for 195 countries from 2000 to 2019 using a Bayesian hierarchical temporal sparse regression model, according to a definition of stillbirth of at least 28 weeks' gestational age. Our model combined covariates with a temporal smoothing process such that estimates were informed by data for country-periods with high quality data, while being based on covariates for country-periods with little or no data on stillbirth rates. Bias and additional uncertainty associated with observations based on alternative stillbirth definitions and source types, and observations that were subject to non-sampling errors, were included in the model. We compared the estimated stillbirth rates and trends to previously reported mortality estimates in children younger than 5 years. Globally in 2019, an estimated 2·0 million babies (90% uncertainty interval [UI] 1·9-2·2) were stillborn at 28 weeks or more of gestation, with a global stillbirth rate of 13·9 stillbirths (90% UI 13·5-15·4) per 1000 total births. Stillbirth rates in 2019 varied widely across regions, from 22·8 stillbirths (19·8-27·7) per 1000 total births in west and central Africa to 2·9 (2·7-3·0) in western Europe. After west and central Africa, eastern and southern Africa and south Asia had the second and third highest stillbirth rates in 2019. The global annual rate of reduction in stillbirth rate was estimated at 2·3% (90% UI 1·7-2·7) from 2000 to 2019, which was lower than the 2·9% (2·5-3·2) annual rate of reduction in neonatal mortality rate (for neonates aged <28 days) and the 4·3% (3·8-4·7) annual rate of reduction in mortality rate among children aged 1-59 months during the same period. Based on the lower bound of the 90% UIs, 114 countries had an estimated decrease in stillbirth rate since 2000, with four countries having a decrease of at least 50·0%, 28 having a decrease of 25·0-49·9%, 50 having a decrease of 10·0-24·9%, and 32 having a decrease of less than 10·0%. For the remaining 81 countries, we found no decrease in stillbirth rate since 2000. Of these countries, 34 were in sub-Saharan Africa, 16 were in east Asia and the Pacific, and 15 were in Latin America and the Caribbean. Progress in reducing the rate of stillbirths has been slow compared with decreases in the mortality rate of children younger than 5 years. Accelerated improvements are most needed in the regions and countries with high stillbirth rates, particularly in sub-Saharan Africa. Future prevention of stillbirths needs increased efforts to raise public awareness, improve data collection, assess progress, and understand public health priorities locally, all of which require investment. Bill & Melinda Gates Foundation and the UK Foreign, Commonwealth and Development Office.

Sections du résumé

BACKGROUND
Stillbirths are a major public health issue and a sensitive marker of the quality of care around pregnancy and birth. The UN Global Strategy for Women's, Children's and Adolescents' Health (2016-30) and the Every Newborn Action Plan (led by UNICEF and WHO) call for an end to preventable stillbirths. A first step to prevent stillbirths is obtaining standardised measurement of stillbirth rates across countries. We estimated stillbirth rates and their trends for 195 countries from 2000 to 2019 and assessed progress over time.
METHODS
For a systematic assessment, we created a dataset of 2833 country-year datapoints from 171 countries relevant to stillbirth rates, including data from registration and health information systems, household-based surveys, and population-based studies. After data quality assessment and exclusions, we used 1531 datapoints to estimate country-specific stillbirth rates for 195 countries from 2000 to 2019 using a Bayesian hierarchical temporal sparse regression model, according to a definition of stillbirth of at least 28 weeks' gestational age. Our model combined covariates with a temporal smoothing process such that estimates were informed by data for country-periods with high quality data, while being based on covariates for country-periods with little or no data on stillbirth rates. Bias and additional uncertainty associated with observations based on alternative stillbirth definitions and source types, and observations that were subject to non-sampling errors, were included in the model. We compared the estimated stillbirth rates and trends to previously reported mortality estimates in children younger than 5 years.
FINDINGS
Globally in 2019, an estimated 2·0 million babies (90% uncertainty interval [UI] 1·9-2·2) were stillborn at 28 weeks or more of gestation, with a global stillbirth rate of 13·9 stillbirths (90% UI 13·5-15·4) per 1000 total births. Stillbirth rates in 2019 varied widely across regions, from 22·8 stillbirths (19·8-27·7) per 1000 total births in west and central Africa to 2·9 (2·7-3·0) in western Europe. After west and central Africa, eastern and southern Africa and south Asia had the second and third highest stillbirth rates in 2019. The global annual rate of reduction in stillbirth rate was estimated at 2·3% (90% UI 1·7-2·7) from 2000 to 2019, which was lower than the 2·9% (2·5-3·2) annual rate of reduction in neonatal mortality rate (for neonates aged <28 days) and the 4·3% (3·8-4·7) annual rate of reduction in mortality rate among children aged 1-59 months during the same period. Based on the lower bound of the 90% UIs, 114 countries had an estimated decrease in stillbirth rate since 2000, with four countries having a decrease of at least 50·0%, 28 having a decrease of 25·0-49·9%, 50 having a decrease of 10·0-24·9%, and 32 having a decrease of less than 10·0%. For the remaining 81 countries, we found no decrease in stillbirth rate since 2000. Of these countries, 34 were in sub-Saharan Africa, 16 were in east Asia and the Pacific, and 15 were in Latin America and the Caribbean.
INTERPRETATION
Progress in reducing the rate of stillbirths has been slow compared with decreases in the mortality rate of children younger than 5 years. Accelerated improvements are most needed in the regions and countries with high stillbirth rates, particularly in sub-Saharan Africa. Future prevention of stillbirths needs increased efforts to raise public awareness, improve data collection, assess progress, and understand public health priorities locally, all of which require investment.
FUNDING
Bill & Melinda Gates Foundation and the UK Foreign, Commonwealth and Development Office.

Identifiants

pubmed: 34454675
pii: S0140-6736(21)01112-0
doi: 10.1016/S0140-6736(21)01112-0
pmc: PMC8417352
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

772-785

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.

Déclaration de conflit d'intérêts

Declaration of interests We declare no competing interests.

Références

Lancet Glob Health. 2016 Feb;4(2):e98-e108
pubmed: 26795602
Lancet. 2015 Nov 21;386(10008):2089-2097
pubmed: 26360240
BJOG. 2014 Sep;121 Suppl 4:141-53
pubmed: 25236649
Pediatrics. 2018 Jul;142(1):
pubmed: 29899042
Lancet Glob Health. 2018 Dec;6(12):e1297-e1308
pubmed: 30361107
BMJ. 2011 Feb 03;342:d346
pubmed: 21292711
Bull World Health Organ. 2018 Dec 01;96(12):806-816
pubmed: 30505028
BJOG. 2018 Nov;125(12):1591-1599
pubmed: 29782696
PLoS One. 2020 Dec 18;15(12):e0243722
pubmed: 33338039
Lancet. 2018 Nov 3;392(10158):1639-1646
pubmed: 30269877
Int J Gynaecol Obstet. 2011 Jun;113(3):199-204
pubmed: 21458812
J Obstet Gynaecol. 2021 Feb;41(2):229-233
pubmed: 32347769
Pediatrics. 2011 May;127(5):e1182-90
pubmed: 21502233
PLoS One. 2019 May 9;14(5):e0215864
pubmed: 31071111
PLoS One. 2016 Dec 28;11(12):e0168743
pubmed: 28030594
Acta Obstet Gynecol Scand. 2011 Dec;90(12):1379-85
pubmed: 21916854
Lancet. 2017 Sep 16;390(10100):1084-1150
pubmed: 28919115
J Perinat Med. 2018 Nov 27;46(9):1022-1027
pubmed: 29267175
Lancet. 2011 Apr 16;377(9774):1319-30
pubmed: 21496917
BMJ. 2013 Jan 24;346:f108
pubmed: 23349424
BJOG. 2020 Feb;127(3):314-318
pubmed: 31580509
Bull World Health Organ. 2018 Dec 1;96(12):861-863
pubmed: 30505035
Cochrane Database Syst Rev. 2020 Mar 25;3:CD012982
pubmed: 32212268
J Stat Softw. 2017;76:
pubmed: 36568334
BJOG. 2018 Jan;125(2):212-224
pubmed: 29193794
Lancet. 2016 Feb 13;387(10019):703-716
pubmed: 26794079
Lancet Glob Health. 2020 Apr;8(4):e555-e566
pubmed: 32199123
Reprod Health. 2015;12 Suppl 2:S1
pubmed: 26063166
Natl Vital Stat Rep. 2020 Apr;69(4):1-20
pubmed: 32510316
Paediatr Perinat Epidemiol. 2019 Jan;33(1):28-44
pubmed: 30698889
S Afr Med J. 2019 Apr 29;109(5):347-352
pubmed: 31131803
Obstet Gynecol. 2017 May;129(5):e150-e154
pubmed: 28426621

Auteurs

Lucia Hug (L)

Division of Data, Analytics, Planning and Monitoring, UNICEF, New York, NY, USA. Electronic address: lhug@unicef.org.

Danzhen You (D)

Division of Data, Analytics, Planning and Monitoring, UNICEF, New York, NY, USA.

Hannah Blencowe (H)

Maternal, Adolescent, Reproductive & Child Health Centre, London School of Hygiene & Tropical Medicine, London, UK.

Anu Mishra (A)

Division of Data, Analytics, Planning and Monitoring, UNICEF, New York, NY, USA.

Zhengfan Wang (Z)

Department of Biostatistics and Epidemiology, University of Massachusetts Amherst, Amherst, MA, USA.

Miranda J Fix (MJ)

University of Washington, Seattle, WA, USA.

Jon Wakefield (J)

University of Washington, Seattle, WA, USA.

Allisyn C Moran (AC)

Department of Maternal, Newborn, Child and Adolescent Health, WHO, Geneva, Switzerland.

Victor Gaigbe-Togbe (V)

UN Population Division, New York, NY, USA.

Emi Suzuki (E)

Development Data Group, World Bank, Washington, DC, USA.

Dianna M Blau (DM)

Centers for Disease Control and Prevention, Atlanta, GA, USA.

Simon Cousens (S)

Maternal, Adolescent, Reproductive & Child Health Centre, London School of Hygiene & Tropical Medicine, London, UK.

Andreea Creanga (A)

Johns Hopkins University, Baltimore, MD, USA.

Trevor Croft (T)

The Demographic and Health Surveys Program, ICF, Rockville, MD, USA.

Kenneth Hill (K)

Stanton-Hill Research, Moultonborough, NH, USA.

K S Joseph (KS)

University of British Columbia, Vancouver, BC, Canada; Children's and Women's Hospital and Health Centre of British Columbia, Vancouver, BC, Canada.

Salome Maswime (S)

University of Cape Town, Cape Town, South Africa.

Elizabeth M McClure (EM)

RTI International, Research Triangle Park, NC, USA.

Robert Pattinson (R)

SAMRC/UP Maternal and Infant Health Care Strategies Unit, Department of Obstetrics and Gynaecology, University of Pretoria, Pretoria, South Africa.

Jon Pedersen (J)

Mikro, Oslo, Norway.

Lucy K Smith (LK)

Department of Health Sciences, University of Leicester, Leicester, UK.

Jennifer Zeitlin (J)

Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team, Center for Epidemiology and Statistics Sorbonne Paris Cité, DHU Risks in Pregnancy, Paris Descartes University, Paris, France.

Leontine Alkema (L)

Department of Biostatistics and Epidemiology, University of Massachusetts Amherst, Amherst, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH